GLENCORE COMMODITIES LTD

Financial Health Assessment: GLENCORE COMMODITIES LTD

1. Financial Health Score: B+

Explanation: The patient exhibits excellent outward signs of compliance and structural stability, boosted significantly by the robust "DNA" provided by its parent company. However, because the detailed quantitative "blood work" (specific balance sheet and profit & loss figures) is not present in this specific examination, a perfect score cannot be awarded. The structural and compliance vitals, however, are in superb condition.

2. Key Vital Signs

• Corporate Pulse (Compliance Status): Strong and steady. The company’s accounts are made up to December 2025 and are not overdue, with the next filing not due until September 2027. The confirmation statement is also current. This indicates a healthy, disciplined administrative heartbeat with no symptoms of regulatory distress.
• Genetic Lineage (Ownership & Backing): Robust. The company is a wholly-owned subsidiary of Glencore UK Ltd, which holds more than 75% of shares, voting rights, and director appointment powers. This is the financial equivalent of having an excellent family health history; the subsidiary benefits from the immense balance sheet and global reach of its parent, effectively inoculating it against the liquidity crises that often strike independent firms in the volatile commodity sector.
• Capital Blood Volume (Share Capital): Adequate. With a share capital of £500,000, the business has a solid foundation of equity. It is not running on empty, though actual working capital levels would need to be verified in the full accounts.
• Organ Function (Officer Stability): Minor surgical shift. There has been a recent change in the boardroom, with Director Xxxxxx Xxxxxxxxname shown to subscribers resigning in March 2026. While current directors Xxxxxx Xxxxxxxxname shown to subscribers and Xxxxxx Xxxxxxxxname shown to subscribers, alongside Secretary Xxxxxx Xxxxxxxxname shown to subscribers, maintain the corporate posture, a resignation is akin to a minor surgical change—it requires monitoring to ensure no institutional knowledge is lost, but it is rarely fatal to the corporate body.

3. Diagnosis

Based on the available qualitative indicators, Glencore Commodities Ltd is a healthy, functioning corporate entity operating within the intensive care unit of the global commodities market (SIC Code 66120). The business shows zero symptoms of financial distress, insolvency, or administrative neglect.

The company's primary health driver is its parentage. Because Glencore UK Ltd holds dominant control, this entity operates less like an independent organism and more like a vital organ within a larger corporate body. Consequently, its individual financial health is inextricably linked to the systemic health of the Glencore group. The recent director resignation presents as a routine corporate tissue rejection—a natural part of organizational evolution rather than a symptom of underlying disease.

4. Recommendations

To maintain and improve financial wellness, the following preventative care measures are recommended: * Monitor the Incision: Ensure the recent departure of Director Xxxxxxxname shown to subscribers is accompanied by a smooth transition of responsibilities. A change in directors can sometimes lead to short-term administrative scarring if internal controls are disrupted. * Conduct Full Blood Work: The current assessment is based on outward signs and corporate structure. To truly assess cardiovascular health (cash flow) and metabolic efficiency (profitability), a thorough review of the latest filed Profit & Loss accounts and Balance Sheet is required. Stakeholders should request these documents to check for hidden symptoms, such as excessive current liabilities or thinning margins. * Maintain Compliance Diet: Continue the excellent regimen of timely filings with Companies House. Late filings act as a fever, attracting regulatory penalties and lowering the company's credit score, which can restrict access to vital trade credit.

Names of the people mentioned are shown to subscribers. See subscription